Mode of action:
Immunostimulant, has antiviral activity. Stimulates the production of interferons alpha and beta, mobilizes and activates macrophages, inhibits the production of inflammatory cytokines (interleykina1, interleykina6, interleykina8 and TNF) stimulates the production of antibodies to various antigens of an infectious nature, inhibits viral replication, increases the body's resistance against infections caused by viruses, bacteria or fungi. Patients infected with HIV, HIV reduces the concentration of blood cells and plasma simultaneously activates immune response specific for HIV. The majority of patients infected with HIV, the treatment leads to increased levels of CD4 T-lymphocytes and NK-cells, enhance the functional activity of neutrophils and CD8 T-lymphocytes, is a key component of defense against bacteria, viruses and fungi, strengthening of the production of antibodies specific to antigens HIV, as well as to the antigens of pathogens of opportunistic infections. The clinical effect is the prevention of recurrence of opportunistic infections within 3-6 months. When topically applied anti-inflammatory effect. Within 1-2 days after treatment significantly reduced signs of inflammation, including redness and swelling, as well as the feeling of pain, burning, itching in the areas of inflammation of the mucous membranes and skin. It removes dryness of mucous.
Correction of immunodeficiency (including HIV infection), increased immune defense against infections. Treatment and prevention of opportunistic infections caused by bacteria, viruses or fungi. Treatment and prevention of candidiasis mucous membranes and skin (including as a result of antibiotic treatment). Inflammatory diseases of the skin, dryness of mucous membranes (local application).
Hypersensitivity, children's age (12 years), pregnancy, lactation.
So far, no side effects detected.
Dosage and administration:
Inside: the dose for adults and children over 12 years - 10 mg 1 time a day. For the treatment of opportunistic infections in HIV infection or other immunodeficiency states - oral, 10 mg 1 time a day for 1-3 months. Local: 1-2 mg 0.02-0.04% as the treatment solution of the mucous membranes and skin 1 times a day. For the treatment and prevention of candidiasis mucous membranes and skin - 3 times at intervals of 1-3 days. When vulvovaginitis, urethritis and cervicitis - irrigation 0.02-0.04% solution of the mucous membrane of the vulva, vagina, cervix, and lotion on the affected areas of the skin adjacent to the entrance to the vagina. If urethritis in men and balanoposthitis - instillation of 0.02-0.04% solution into the urethra and lotions on the affected skin. Treatment of mucous membranes and skin was repeated three times at intervals of 1-3 days. For the prevention of mucosal candidiasis and skin with antibiotic therapy - irrigation (lotion) 0.02-0.04% solution during the course of antibiotic therapy.